CD8 + T-cell Density Is an Independent Predictor of Survival and Response to Adjuvant Chemotherapy in Stage III Colon Cancer.

MLA

Garcia, Paulo, et al. “CD8 + T-Cell Density Is an Independent Predictor of Survival and Response to Adjuvant Chemotherapy in Stage III Colon Cancer.” Applied Immunohistochemistry & Molecular Morphology : AIMM, vol. 31, no. 2, Feb. 2023, pp. 69–76. EBSCOhost, https://doi.org/10.1097/PAI.0000000000001094.

APA

Garcia, P., Hartman, D., Choudry, H., & Pai, R. K. (2023). CD8 + T-cell Density Is an Independent Predictor of Survival and Response to Adjuvant Chemotherapy in Stage III Colon Cancer. Applied Immunohistochemistry & Molecular Morphology : AIMM, 31(2), 69–76. https://doi.org/10.1097/PAI.0000000000001094

Chicago

Garcia, Paulo, Douglas Hartman, Haroon Choudry, and Reetesh K Pai. 2023. “CD8 + T-Cell Density Is an Independent Predictor of Survival and Response to Adjuvant Chemotherapy in Stage III Colon Cancer.” Applied Immunohistochemistry & Molecular Morphology : AIMM 31 (2): 69–76. doi:10.1097/PAI.0000000000001094.